Last modified: 22 May 2019 17:07
This course will describe the basic language of business and give examples of large versus small businesses in the bioscience area. Intellectual property rights will be explained as will how present your business and how to set up a small biotech company. A comparison will be made of the big Pharma business model and that of small biotech businesses.
|Session||First Sub Session||Credit Points||15 credits (7.5 ECTS credits)|
This course will challenge you to think about the nature of research when driven by commercial outcomes. Future recruitment opportunities may involve roles in bio-business development rather than exclusively research at the bench. This course hopes to place you at a competitive advantage when seeking such career paths. In the biotechnology arena the commercial process of drug discovery and development costs significant sums but the risks of failure are also very high. You will gain insight into the way this risk and cost is managed against the very large potential revenues that could be generated from a successful drug pipeline.
This is the total time spent in lectures, tutorials and other class teaching.
1 Essay (under examination conditions) (40%); 1 problem solving assignment (25%); 1 Presentation (35%).
There are no assessments for this course.